Literature DB >> 2055056

Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products.

E A Deitch1, R D Specian, R D Berg.   

Abstract

BACKGROUND AND METHODS: Previously, we documented that nonlethal doses of endotoxin injure the intestinal mucosal barrier and promote bacterial translocation from the gut to systemic organs. The current study was performed to determine the role of cytokines and complement activation in the pathogenesis of endotoxin-induced mucosal injury and bacterial translocation, as well as to quantify the magnitude of endotoxin-induced intestinal mucosal permeability.
RESULTS: The frequency of endotoxin-induced bacterial translocation was similar between normal outbred (88%), complement deficient (67%), and macrophage-hyporesponsive (55%) mice, indicating that neither complement nor macrophage activation is necessary for endotoxin-induced bacterial translocation to occur. As early as 2 hrs after endotoxin challenge, there was evidence of a greater than two-fold increase in ileal (p = .008) but not jejunal (p = .11) permeability as measured by the clearance of 51Cr EDTA. Both the increase in endotoxin-induced ileal permeability and the occurrence of bacterial translocation were largely prevented by pretreatment with allopurinol, a competitive inhibitor of xanthine oxidase.
CONCLUSIONS: These results suggest that endotoxin-induced bacterial translocation, mucosal injury, and ileal permeability are mediated via activation of xanthine oxidase, and not through complement activation or the liberation of macrophage products.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055056     DOI: 10.1097/00003246-199106000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis.

Authors:  Nicolas T Schwarz; Donna Beer-Stolz; Richard L Simmons; Anthony J Bauer
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

Authors:  Melissa J Puppa; James P White; Shuichi Sato; Mark Cairns; John W Baynes; James A Carson
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 3.  The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome.

Authors:  G A Nieuwenhuijzen; E A Deitch; R J Goris
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

4.  Clinical outcome of collateral ligament injuries of the tarsus.

Authors:  Lauren Lamb; Chad Zubrod; Brent Hague; Jeff Brakenhoff; Michael Major
Journal:  Can Vet J       Date:  2012-05       Impact factor: 1.008

5.  Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation.

Authors:  T Tadros; D L Traber; J P Heggers; D N Herndon
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

6.  Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation.

Authors:  Chao Yue; Bingqiang Ma; Yunzhao Zhao; Qiurong Li; Jieshou Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

7.  Role of bacterial adherence and the mucus barrier on bacterial translocation: effects of protein malnutrition and endotoxin in rats.

Authors:  M Katayama; D Xu; R D Specian; E A Deitch
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

8.  Effect of endotoxin administration on the severity of acute pancreatitis in two experimental models.

Authors:  J Pozsár; R Schwab; K Simon; L Fekete; G Orgován; A Pap
Journal:  Int J Pancreatol       Date:  1997-08

9.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Combination of allopurinol and hyperbaric oxygen therapy: a new treatment in experimental acute necrotizing pancreatitis?

Authors:  Bilgin Comert; Ahmet Turan Isik; Sezai Aydin; Ergun Bozoglu; Bulent Unal; Salih Deveci; Nuket Mas; Esref Cinar; Mehmet Refik Mas
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.